-- Disclosure of eIF4E, a regulator of oncoprotein translation, as target of most advanced program ---- Data demonstrate strong in vivo anti-tumor effects of orally bioavailable small molecules; IND enabling studies planned ---- Additional data to be presented at San Antonio Breast Cancer Symposium in early December...